SIALYL LEWISX(CD15s) MONITORING AS A MEANS TO SELECT ANTIREJECTION THERAPY IN PATIENTS WITH REJECTION AFTER RENAL TRANSPLANTATION

Sialyl LewisX(CD15s), which is known to serve as a ligand for the cell adhesion molecules E-selectin and P-selectin, is expressed on peripheral lymphocytes in renal transplant patients with rejection. In this study, we examined whether CD15s monitoring could differentiate the patients with rejection in whom steroids were effective from those in whom steroids were not effective.